Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection
- 30 April 1998
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 707 (1-2) , 219-225
- https://doi.org/10.1016/s0378-4347(97)00610-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Sensitive and Simple High-Performance Liquid Chromatographic Method for the Determination of Doxorubicin and Its Metabolites in PlasmaTherapeutic Drug Monitoring, 1993
- EpirubicinDrugs, 1993
- Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1992
- Original article: Pharmacokinetics and metabolism of epirubicin administered as i.v. bolus and 48-h infusion in patients with advanced soft-tissue sarcomaAnnals of Oncology, 1992
- Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drugCancer Chemotherapy and Pharmacology, 1990
- Clinical Pharmacokinetics of DoxorubicinClinical Pharmacokinetics, 1988
- Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4′-epidoxorubicinEuropean Journal of Cancer and Clinical Oncology, 1984
- Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975